je.st
news
China Biotech In Review: Eli Lilly Joins The Big Pharmas Accused Of Bribing In China
2013-08-25 10:18:37| Biotech - Topix.net
MicuRx Pharmaceuticals, a San Francisco-Shanghai antibiotics company, raised $25 million in Series B financing.
Tags: review
big
china
accused
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|